Trademark: TRIALMAX SYNAPSE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TRIALMAX SYNAPSE
Click here to search for trademarks similar to TRIALMAX SYNAPSE
Proof of use for TRIALMAX SYNAPSE
We do not have any records of a proof of use for TRIALMAX SYNAPSE at this moment.
Possible trademark infringements of TRIALMAX SYNAPSE
Basic Information about TRIALMAX SYNAPSE
- Serial Number
- 85539756
- Filing Date
- 10 Feb 2012
- Registration Number
- 4808779
- Registration Date
- 08 Sep 2015
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TRIALMAX SYNAPSE on the blockchain with WikiTrademarks.io.
- First use of TRIALMAX SYNAPSE anywhere
- TRIALMAX SYNAPSE was first used on 01 Jan 2013 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 042
- US Codes
- 100; 101
Who owns TRIALMAX SYNAPSE?
1. SIGNANT HEALTH LLC BLUE BELL PA
2. SIGNANT HEALTH INC. BLUE BELL PA
3. CRF, Inc. Plymouth Meeting PA
4. CRF, Inc. Plymouth Meeting PA
5. CRF, Inc. Plymouth Meeting PA
Correspondent
- Anna Kurian Shaw
- Hogan Lovells US LLP
- 555 13th Street NW
- Washington DC 20004
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io